Catalyst Wire Dossier Catalyst Wire Dossier

JENCYCLA

NORETHINDRONE · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JENCYCLA, covering 2013-03-28 to 2023-05-30. Get the full timeline:

Most recent: FDA Approved: JENCYCLA — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing